ExscientiaEXAI
Market Cap: $660M
About: Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe, and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.
Employees: 483
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0% more funds holding in top 10
Funds holding in top 10: 4 [Q1] → 4 (+0) [Q2]
9% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 22
2.92% less ownership
Funds ownership: 25.14% [Q1] → 22.22% (-2.92%) [Q2]
4% less funds holding
Funds holding: 78 [Q1] → 75 (-3) [Q2]
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
21% less capital invested
Capital invested by funds: $181M [Q1] → $143M (-$38.2M) [Q2]
84% less call options, than puts
Call options by funds: $176K | Put options by funds: $1.08M
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
Barclays Peter Lawson 23% 1-year accuracy 6 / 26 met price target | 4%downside $5 | Equal-Weight Downgraded | 13 Aug 2024 |
Barclays Peter Lawson 23% 1-year accuracy 6 / 26 met price target | 73%upside $9 | Overweight Maintained | 29 Jul 2024 |
Financial journalist opinion
Based on 6 articles about EXAI published over the past 30 days